Characterization of the inflammatory response to solid cancer metastases in the human brain

Clinical and Experimental Metastasis

Volumn 30, Issue 1, 2013, Pages 69-81

  Berghoff, Anna Sophie ^a,b   Lassmann, Hans ^c   Preusser, Matthias ^b   Höftberger, Romana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Medical University of Vienna   (Austria)

Author keywords

Adaptive immune system; Brain metastases; Immune system; Innate immune system; Lymphocytes; Macrophages; Microglia

Indexed keywords

CD8 ANTIGEN; GRANZYME B; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BRAIN METASTASIS; BREAST CANCER; CANCER PATIENT; CELL POPULATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MELANOMA; MICROGLIA; PHAGOCYTOSIS; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MACROPHAGES; MALE; MELANOMA; MICROGLIA; MIDDLE AGED; SMALL CELL LUNG CARCINOMA;

EID: 84872686569     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9510-4     Document Type: Article

References (57)

1. Kamar FG, Posner JB (2010) Brain metastases. Semin Neurol 30(3):217-235
2. Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486-2493
3. Kienast Y, Winkler F (2010) Therapy and prophylaxis of brain metastases. Expert Rev Anticancer Ther 10(11):1763-1777
4. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745-751
5. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30(4):419-425
6. Mehta MP, Paleologos NA, Mikkelsen T, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, McDermott M, Olson JJ, Patchell RA, Ryken TC, Kalkanis SN (2010) The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1):71-83
7. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13(7):674-681
8. Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A (2012) Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol 123(2):205-222
9. Margolin K, Ernstoff MS, Hamid O, Lawrence D, McDermott D, Puzanov I, Wolchok JD, Clark JI, Sznol M, Logan TF, Richards J, Michener T, Balogh A, Heller KN, Hodi FS (2012) Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Lancet Oncol 13(5):459-465
10. Sriram S (2011) Role of glial cells in innate immunity and their role in CNS demyelination. J Neuroimmunol 239(1-2):13-20
11. Graeber MB, Scheithauer BW, Kreutzberg GW (2002) Microglia in brain tumors. Glia 40(2):252-259
12. Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119(1):89-105
13. Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in neurodegenerative diseases. Immunology 129(2):154-169
14. He BP, Wang JJ, Zhang X, Wu Y, Wang M, Bay BH, Chang AY (2006) Differential reactions of microglia to brain metastasis of lung cancer. Mol Med 12(7-8):161-170
15. Zhang M, Olsson Y (1995) Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells. J Neurol Sci 134(1-2):26-32
16. Mittelbronn M, Platten M, Zeiner P, Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M, Wischhusen J (2011) Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathol 122(3):353-365
17. Mittelbronn M, Simon P, Loffler C, Capper D, Bunz B, Harter P, Schlaszus H, Schleich A, Tabatabai G, Goeppert B, Meyermann R, Weller M, Wischhusen J (2007) Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells. J Neuroimmunol 189(1-2):50-58
18. Roth P, Eisele G, Weller M (2012) Immunology of brain tumors. Handb Clin Neurol 104:45-51
19. Dunn GP, Fecci PE, Curry WT (2012) Cancer immunoediting in malignant glioma. Neurosurgery. doi: 10.1227/NEU.0b013e31824f840d
20. Neves S, Mazal PR, Wanschitz J, Rudnay AC, Drlicek M, Czech T, Wustinger C, Budka H (2001) Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol 20(1):38-42
21. De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW (2008) Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. Clin Cancer Res 14(10):3098-3104
22. Weber JS, Amin A, Minor D, Siegel J, Berman D, O'Day SJ (2011) Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial. Melanoma Res 21(6):530-534
23. Finocchiaro G, Pellegatta S (2011) Immunotherapy for glioma: getting closer to the clinical arena? Curr Opin Neurol 24(6):641-647
24. Dringen R (2005) Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7(9-10):1223-1233
25. Daginakatte GC, Gutmann DH (2007) Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 16(9):1098-1112
26. Brantley EC, Guo L, Zhang C, Lin Q, Yokoi K, Langley RR, Kruzel E, Maya M, Kim SW, Kim SJ, Fan D, Fidler IJ (2010) Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl Oncol 3(6):380-388
27. Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H (2008) Multiple sclerosis and Alzheimer's disease. Ann Neurol 63(2):174-183
28. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134(Pt 7):1914-1924
29. Kamata T (2009) Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100(8):1382-1388
30. Murata J, Corradin SB, Janzer RC, Juillerat-Jeanneret L (1994) Tumor cells suppress cytokine-induced nitric-oxide (NO) production in cerebral endothelial cells. Int J Cancer 59(5):699-705
31. Noda M, Seike T, Fujita K, Yamakawa Y, Kido M, Iguchi H (2009) The role of immune cells in brain metastasis of lung cancer cells and neuron-tumor cell interaction. Ross Fiziol Zh Im I M Sechenova 95(12):1386-1396
32. Strik HM, Stoll M, Meyermann R (2004) Immune cell infiltration of intrinsic and metastatic intracranial tumours. Anticancer Res 24(1):37-42
33. Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, Tan Z, Fang M, Rui L, Chen D, Wang S, Zheng X, Wang CY, Gong F (2007) Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 7(4):799-808
34. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960-1964
35. de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW (2009) Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol 114(1):105-110
36. Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG, Daemen T, Nijman HW (2009) Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 58(3):449-459
37. Robert C, Thomas L, Bondarenko I, O'Day S, M DJ, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH, Jr., Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364(26): 2517-2526
38. Loeffler C, Dietz K, Schleich A, Schlaszus H, Stoll M, Meyermann R, Mittelbronn M (2011) Immune surveillance of the normal human CNS takes place in dependence of the locoregional blood-brain barrier configuration and is mainly performed by CD3(+)/CD8(+) lymphocytes. Neuropathology 31(3):230-238
39. Bradl M, Hohlfeld R (2003) Molecular pathogenesis of neuroinflammation. J Neurol Neurosurg Psychiatry 74(10):1364-1370
40. Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM (2011) Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 17(6):1603-1615
41. Roth P, Mittelbronn M, Wick W, Meyermann R, Tatagiba M, Weller M (2007) Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. Cancer Res 67(8):3540-3544
42. Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H (2007) WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Acta Neuropathol 114(2):111-119
43. Schneider T, Becker A, Ringe K, Reinhold A, Firsching R, Sabel BA (2008) Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles. J Neuroimmunol 195(1-2):21-27
44. Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50(4):427-434
45. Unanue ER (2002) Perspective on antigen processing and presentation. Immunol Rev 185:86-102
46. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL (1990) HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 2(2):113-125
47. Mattiace LA, Davies P, Dickson DW (1990) Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 136(5):1101-1114
48. Martinez-Pomares L, Platt N, McKnight AJ, da Silva RP, Gordon S (1996) Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 195(4-5):407-416
49. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 57(1):1-9
50. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, Dickson DW (2007) Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. J Histochem Cytochem 55(7):687-700
51. Avril T, Attrill H, Zhang J, Raper A, Crocker PR (2006) Negative regulation of leucocyte functions by CD33-related siglecs. Biochem Soc Trans 34(Pt 6):1024-1027
52. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H (2002) Destruction of neurons by cytotoxic T-cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 51(3):311-318
53. Payne J, Maher F, Simpson I, Mattice L, Davies P (1997) Glucose transporter Glut 5 expression in microglial cells. Glia 21(3):327-331
54. Smith KJ, Lassmann H (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol 1(4):232-241
55. Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, LeVine H 3rd, Keller JN, Markesbery WR (2010) NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 12(12):1371-1382
56. Janeway CA (2002) Immunology, 5 edn. Garland Publishing, Heidelberg
57. Rousalova I, Krepela E (2010) Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int J Oncol 37(6):1361-1378